img

Global Non-invasive Parenteral Screening Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Non-invasive Parenteral Screening Market Research Report 2024

Non-invasive Parenteral Screening is a nascent genetic process of examining a fetal cell free DNA present in the mothers blood serum for detecting common fetal aneuploidies. Its main objective is early detection of genetic disorders such as trisomy 21 (Down syndrome), trisomy 18 (Edward syndrome), trisomy 13 (Patau syndrome), and monosomy X (Turner syndrome). It can also detect the blood group and rhesus actor of the fetus. Some of the NIPTs currently available in the global market are MaterniT21 PLUS, Harmony, Panorama, NIFTY, PrenaTest, BambniTest, and others.
According to MRAResearch’s new survey, global Non-invasive Parenteral Screening market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Non-invasive Parenteral Screening market research.
Key companies engaged in the Non-invasive Parenteral Screening industry include GE Healthcare, Philips, Illumina, Thermo Fisher Scientific, Roche, PacBio, Perkinelmer, Qiagen and Agilent Technologies, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Non-invasive Parenteral Screening were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Non-invasive Parenteral Screening market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Non-invasive Parenteral Screening market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


GE Healthcare
Philips
Illumina
Thermo Fisher Scientific
Roche
PacBio
Perkinelmer
Qiagen
Agilent Technologies
BGI Group
Segment by Type
Instruments
Consumables

Segment by Application


Diagnostic Laboratories
Hospitals
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Non-invasive Parenteral Screening report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-invasive Parenteral Screening Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Instruments
1.2.3 Consumables
1.3 Market by Application
1.3.1 Global Non-invasive Parenteral Screening Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Non-invasive Parenteral Screening Market Perspective (2018-2033)
2.2 Non-invasive Parenteral Screening Growth Trends by Region
2.2.1 Global Non-invasive Parenteral Screening Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Non-invasive Parenteral Screening Historic Market Size by Region (2018-2023)
2.2.3 Non-invasive Parenteral Screening Forecasted Market Size by Region (2024-2033)
2.3 Non-invasive Parenteral Screening Market Dynamics
2.3.1 Non-invasive Parenteral Screening Industry Trends
2.3.2 Non-invasive Parenteral Screening Market Drivers
2.3.3 Non-invasive Parenteral Screening Market Challenges
2.3.4 Non-invasive Parenteral Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-invasive Parenteral Screening Players by Revenue
3.1.1 Global Top Non-invasive Parenteral Screening Players by Revenue (2018-2023)
3.1.2 Global Non-invasive Parenteral Screening Revenue Market Share by Players (2018-2023)
3.2 Global Non-invasive Parenteral Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Non-invasive Parenteral Screening Revenue
3.4 Global Non-invasive Parenteral Screening Market Concentration Ratio
3.4.1 Global Non-invasive Parenteral Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-invasive Parenteral Screening Revenue in 2022
3.5 Non-invasive Parenteral Screening Key Players Head office and Area Served
3.6 Key Players Non-invasive Parenteral Screening Product Solution and Service
3.7 Date of Enter into Non-invasive Parenteral Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-invasive Parenteral Screening Breakdown Data by Type
4.1 Global Non-invasive Parenteral Screening Historic Market Size by Type (2018-2023)
4.2 Global Non-invasive Parenteral Screening Forecasted Market Size by Type (2024-2033)
5 Non-invasive Parenteral Screening Breakdown Data by Application
5.1 Global Non-invasive Parenteral Screening Historic Market Size by Application (2018-2023)
5.2 Global Non-invasive Parenteral Screening Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Non-invasive Parenteral Screening Market Size (2018-2033)
6.2 North America Non-invasive Parenteral Screening Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Non-invasive Parenteral Screening Market Size by Country (2018-2023)
6.4 North America Non-invasive Parenteral Screening Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Non-invasive Parenteral Screening Market Size (2018-2033)
7.2 Europe Non-invasive Parenteral Screening Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Non-invasive Parenteral Screening Market Size by Country (2018-2023)
7.4 Europe Non-invasive Parenteral Screening Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Non-invasive Parenteral Screening Market Size (2018-2033)
8.2 Asia-Pacific Non-invasive Parenteral Screening Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Non-invasive Parenteral Screening Market Size by Region (2018-2023)
8.4 Asia-Pacific Non-invasive Parenteral Screening Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Non-invasive Parenteral Screening Market Size (2018-2033)
9.2 Latin America Non-invasive Parenteral Screening Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Non-invasive Parenteral Screening Market Size by Country (2018-2023)
9.4 Latin America Non-invasive Parenteral Screening Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-invasive Parenteral Screening Market Size (2018-2033)
10.2 Middle East & Africa Non-invasive Parenteral Screening Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Non-invasive Parenteral Screening Market Size by Country (2018-2023)
10.4 Middle East & Africa Non-invasive Parenteral Screening Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Detail
11.1.2 GE Healthcare Business Overview
11.1.3 GE Healthcare Non-invasive Parenteral Screening Introduction
11.1.4 GE Healthcare Revenue in Non-invasive Parenteral Screening Business (2018-2023)
11.1.5 GE Healthcare Recent Development
11.2 Philips
11.2.1 Philips Company Detail
11.2.2 Philips Business Overview
11.2.3 Philips Non-invasive Parenteral Screening Introduction
11.2.4 Philips Revenue in Non-invasive Parenteral Screening Business (2018-2023)
11.2.5 Philips Recent Development
11.3 Illumina
11.3.1 Illumina Company Detail
11.3.2 Illumina Business Overview
11.3.3 Illumina Non-invasive Parenteral Screening Introduction
11.3.4 Illumina Revenue in Non-invasive Parenteral Screening Business (2018-2023)
11.3.5 Illumina Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Non-invasive Parenteral Screening Introduction
11.4.4 Thermo Fisher Scientific Revenue in Non-invasive Parenteral Screening Business (2018-2023)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Non-invasive Parenteral Screening Introduction
11.5.4 Roche Revenue in Non-invasive Parenteral Screening Business (2018-2023)
11.5.5 Roche Recent Development
11.6 PacBio
11.6.1 PacBio Company Detail
11.6.2 PacBio Business Overview
11.6.3 PacBio Non-invasive Parenteral Screening Introduction
11.6.4 PacBio Revenue in Non-invasive Parenteral Screening Business (2018-2023)
11.6.5 PacBio Recent Development
11.7 Perkinelmer
11.7.1 Perkinelmer Company Detail
11.7.2 Perkinelmer Business Overview
11.7.3 Perkinelmer Non-invasive Parenteral Screening Introduction
11.7.4 Perkinelmer Revenue in Non-invasive Parenteral Screening Business (2018-2023)
11.7.5 Perkinelmer Recent Development
11.8 Qiagen
11.8.1 Qiagen Company Detail
11.8.2 Qiagen Business Overview
11.8.3 Qiagen Non-invasive Parenteral Screening Introduction
11.8.4 Qiagen Revenue in Non-invasive Parenteral Screening Business (2018-2023)
11.8.5 Qiagen Recent Development
11.9 Agilent Technologies
11.9.1 Agilent Technologies Company Detail
11.9.2 Agilent Technologies Business Overview
11.9.3 Agilent Technologies Non-invasive Parenteral Screening Introduction
11.9.4 Agilent Technologies Revenue in Non-invasive Parenteral Screening Business (2018-2023)
11.9.5 Agilent Technologies Recent Development
11.10 BGI Group
11.10.1 BGI Group Company Detail
11.10.2 BGI Group Business Overview
11.10.3 BGI Group Non-invasive Parenteral Screening Introduction
11.10.4 BGI Group Revenue in Non-invasive Parenteral Screening Business (2018-2023)
11.10.5 BGI Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Non-invasive Parenteral Screening Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Instruments
Table 3. Key Players of Consumables
Table 4. Global Non-invasive Parenteral Screening Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Non-invasive Parenteral Screening Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Non-invasive Parenteral Screening Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Non-invasive Parenteral Screening Market Share by Region (2018-2023)
Table 8. Global Non-invasive Parenteral Screening Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Non-invasive Parenteral Screening Market Share by Region (2024-2033)
Table 10. Non-invasive Parenteral Screening Market Trends
Table 11. Non-invasive Parenteral Screening Market Drivers
Table 12. Non-invasive Parenteral Screening Market Challenges
Table 13. Non-invasive Parenteral Screening Market Restraints
Table 14. Global Non-invasive Parenteral Screening Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Non-invasive Parenteral Screening Market Share by Players (2018-2023)
Table 16. Global Top Non-invasive Parenteral Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Parenteral Screening as of 2022)
Table 17. Ranking of Global Top Non-invasive Parenteral Screening Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Non-invasive Parenteral Screening Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Non-invasive Parenteral Screening Product Solution and Service
Table 21. Date of Enter into Non-invasive Parenteral Screening Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Non-invasive Parenteral Screening Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Non-invasive Parenteral Screening Revenue Market Share by Type (2018-2023)
Table 25. Global Non-invasive Parenteral Screening Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Non-invasive Parenteral Screening Revenue Market Share by Type (2024-2033)
Table 27. Global Non-invasive Parenteral Screening Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Non-invasive Parenteral Screening Revenue Market Share by Application (2018-2023)
Table 29. Global Non-invasive Parenteral Screening Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Non-invasive Parenteral Screening Revenue Market Share by Application (2024-2033)
Table 31. North America Non-invasive Parenteral Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Non-invasive Parenteral Screening Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Non-invasive Parenteral Screening Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Non-invasive Parenteral Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Non-invasive Parenteral Screening Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Non-invasive Parenteral Screening Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Non-invasive Parenteral Screening Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Non-invasive Parenteral Screening Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Non-invasive Parenteral Screening Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Non-invasive Parenteral Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Non-invasive Parenteral Screening Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Non-invasive Parenteral Screening Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Non-invasive Parenteral Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Non-invasive Parenteral Screening Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Non-invasive Parenteral Screening Market Size by Country (2024-2033) & (US$ Million)
Table 46. GE Healthcare Company Detail
Table 47. GE Healthcare Business Overview
Table 48. GE Healthcare Non-invasive Parenteral Screening Product
Table 49. GE Healthcare Revenue in Non-invasive Parenteral Screening Business (2018-2023) & (US$ Million)
Table 50. GE Healthcare Recent Development
Table 51. Philips Company Detail
Table 52. Philips Business Overview
Table 53. Philips Non-invasive Parenteral Screening Product
Table 54. Philips Revenue in Non-invasive Parenteral Screening Business (2018-2023) & (US$ Million)
Table 55. Philips Recent Development
Table 56. Illumina Company Detail
Table 57. Illumina Business Overview
Table 58. Illumina Non-invasive Parenteral Screening Product
Table 59. Illumina Revenue in Non-invasive Parenteral Screening Business (2018-2023) & (US$ Million)
Table 60. Illumina Recent Development
Table 61. Thermo Fisher Scientific Company Detail
Table 62. Thermo Fisher Scientific Business Overview
Table 63. Thermo Fisher Scientific Non-invasive Parenteral Screening Product
Table 64. Thermo Fisher Scientific Revenue in Non-invasive Parenteral Screening Business (2018-2023) & (US$ Million)
Table 65. Thermo Fisher Scientific Recent Development
Table 66. Roche Company Detail
Table 67. Roche Business Overview
Table 68. Roche Non-invasive Parenteral Screening Product
Table 69. Roche Revenue in Non-invasive Parenteral Screening Business (2018-2023) & (US$ Million)
Table 70. Roche Recent Development
Table 71. PacBio Company Detail
Table 72. PacBio Business Overview
Table 73. PacBio Non-invasive Parenteral Screening Product
Table 74. PacBio Revenue in Non-invasive Parenteral Screening Business (2018-2023) & (US$ Million)
Table 75. PacBio Recent Development
Table 76. Perkinelmer Company Detail
Table 77. Perkinelmer Business Overview
Table 78. Perkinelmer Non-invasive Parenteral Screening Product
Table 79. Perkinelmer Revenue in Non-invasive Parenteral Screening Business (2018-2023) & (US$ Million)
Table 80. Perkinelmer Recent Development
Table 81. Qiagen Company Detail
Table 82. Qiagen Business Overview
Table 83. Qiagen Non-invasive Parenteral Screening Product
Table 84. Qiagen Revenue in Non-invasive Parenteral Screening Business (2018-2023) & (US$ Million)
Table 85. Qiagen Recent Development
Table 86. Agilent Technologies Company Detail
Table 87. Agilent Technologies Business Overview
Table 88. Agilent Technologies Non-invasive Parenteral Screening Product
Table 89. Agilent Technologies Revenue in Non-invasive Parenteral Screening Business (2018-2023) & (US$ Million)
Table 90. Agilent Technologies Recent Development
Table 91. BGI Group Company Detail
Table 92. BGI Group Business Overview
Table 93. BGI Group Non-invasive Parenteral Screening Product
Table 94. BGI Group Revenue in Non-invasive Parenteral Screening Business (2018-2023) & (US$ Million)
Table 95. BGI Group Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-invasive Parenteral Screening Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Non-invasive Parenteral Screening Market Share by Type: 2022 VS 2033
Figure 3. Instruments Features
Figure 4. Consumables Features
Figure 5. Global Non-invasive Parenteral Screening Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Non-invasive Parenteral Screening Market Share by Application: 2022 VS 2033
Figure 7. Diagnostic Laboratories Case Studies
Figure 8. Hospitals Case Studies
Figure 9. Non-invasive Parenteral Screening Report Years Considered
Figure 10. Global Non-invasive Parenteral Screening Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 11. Global Non-invasive Parenteral Screening Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 12. Global Non-invasive Parenteral Screening Market Share by Region: 2022 VS 2033
Figure 13. Global Non-invasive Parenteral Screening Market Share by Players in 2022
Figure 14. Global Top Non-invasive Parenteral Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Parenteral Screening as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Non-invasive Parenteral Screening Revenue in 2022
Figure 16. North America Non-invasive Parenteral Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 17. North America Non-invasive Parenteral Screening Market Share by Country (2018-2033)
Figure 18. United States Non-invasive Parenteral Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. Canada Non-invasive Parenteral Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Europe Non-invasive Parenteral Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Non-invasive Parenteral Screening Market Share by Country (2018-2033)
Figure 22. Germany Non-invasive Parenteral Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. France Non-invasive Parenteral Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. U.K. Non-invasive Parenteral Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Italy Non-invasive Parenteral Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Russia Non-invasive Parenteral Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Nordic Countries Non-invasive Parenteral Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Asia-Pacific Non-invasive Parenteral Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Non-invasive Parenteral Screening Market Share by Region (2018-2033)
Figure 30. China Non-invasive Parenteral Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Japan Non-invasive Parenteral Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. South Korea Non-invasive Parenteral Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Southeast Asia Non-invasive Parenteral Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. India Non-invasive Parenteral Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Australia Non-invasive Parenteral Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Latin America Non-invasive Parenteral Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Non-invasive Parenteral Screening Market Share by Country (2018-2033)
Figure 38. Mexico Non-invasive Parenteral Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Brazil Non-invasive Parenteral Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Middle East & Africa Non-invasive Parenteral Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Non-invasive Parenteral Screening Market Share by Country (2018-2033)
Figure 42. Turkey Non-invasive Parenteral Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Saudi Arabia Non-invasive Parenteral Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. GE Healthcare Revenue Growth Rate in Non-invasive Parenteral Screening Business (2018-2023)
Figure 45. Philips Revenue Growth Rate in Non-invasive Parenteral Screening Business (2018-2023)
Figure 46. Illumina Revenue Growth Rate in Non-invasive Parenteral Screening Business (2018-2023)
Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Non-invasive Parenteral Screening Business (2018-2023)
Figure 48. Roche Revenue Growth Rate in Non-invasive Parenteral Screening Business (2018-2023)
Figure 49. PacBio Revenue Growth Rate in Non-invasive Parenteral Screening Business (2018-2023)
Figure 50. Perkinelmer Revenue Growth Rate in Non-invasive Parenteral Screening Business (2018-2023)
Figure 51. Qiagen Revenue Growth Rate in Non-invasive Parenteral Screening Business (2018-2023)
Figure 52. Agilent Technologies Revenue Growth Rate in Non-invasive Parenteral Screening Business (2018-2023)
Figure 53. BGI Group Revenue Growth Rate in Non-invasive Parenteral Screening Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed